JPS51110573A - - Google Patents
Info
- Publication number
- JPS51110573A JPS51110573A JP51020544A JP2054476A JPS51110573A JP S51110573 A JPS51110573 A JP S51110573A JP 51020544 A JP51020544 A JP 51020544A JP 2054476 A JP2054476 A JP 2054476A JP S51110573 A JPS51110573 A JP S51110573A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19752507782 DE2507782A1 (de) | 1975-02-22 | 1975-02-22 | Tetralon- und indanon-derivate sowie verfahren zu ihrer herstellung |
| DE19752556196 DE2556196A1 (de) | 1975-12-13 | 1975-12-13 | Tetralon- und indanon-derivate sowie verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS51110573A true JPS51110573A (US08118993-20120221-C00002.png) | 1976-09-30 |
Family
ID=25768542
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51020544A Pending JPS51110573A (US08118993-20120221-C00002.png) | 1975-02-22 | 1976-02-23 |
Country Status (16)
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005085228A1 (ja) * | 2004-03-05 | 2005-09-15 | Banyu Pharmaceutical Co., Ltd. | シクロアルカノピリジン誘導体 |
| JP2015528811A (ja) * | 2012-07-27 | 2015-10-01 | バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． | Ｓ１ｐ調節剤および／またはａｔｘ調節剤である化合物 |
| JP2020533328A (ja) * | 2017-09-07 | 2020-11-19 | タイワンジェ ファーマシューティカルズ カンパニー リミテッドＴａｉｗａｎｊ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏ．， Ｌｔｄ． | ベンゼン縮合複素環誘導体およびその医薬組成物 |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2177085A (en) * | 1985-06-18 | 1987-01-14 | Ici Plc | Fungicidal compounds and compositions |
| HU222726B1 (hu) * | 1990-02-06 | 2003-09-29 | Pfizer, Inc., | Piperidinszármazékok, eljárás elżállításukra és az ezeket tartalmazó gyógyszerkészítmények |
| EP0535496A1 (en) * | 1991-09-25 | 1993-04-07 | Hoechst-Roussel Pharmaceuticals Incorporated | (1-Indanon-2yl)methylpiperidines, intermediates and a process for their preparation and their use as medicaments |
| DE4140542A1 (de) * | 1991-12-09 | 1993-06-17 | Bayer Ag | Piperdylmethyl substituierte chormanderivate |
| US5436255A (en) * | 1992-07-23 | 1995-07-25 | Pfizer Inc. | Method of treating diseases susceptable to treatment by blocking NMDA-receptors |
| AU684568B2 (en) * | 1994-01-31 | 1997-12-18 | Pfizer Inc. | Neuroprotective chroman compounds |
| CA2220649C (en) | 1996-12-03 | 2007-02-13 | F. Hoffmann-La Roche Ag | 4-hydroxy-piperidine derivatives |
| CA2556914A1 (en) | 2004-02-25 | 2005-09-09 | La Jolla Pharmaceutical Company | Amines and amides for the treatment of diseases |
| CA2884179C (en) | 2012-09-14 | 2021-05-04 | Supernus Pharmaceuticals Inc. | Methods of producing molindone and its salts |
| CN115073435B (zh) * | 2022-06-24 | 2023-11-28 | 西北大学 | 一种检测硫化氢的近红外荧光探针及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2820817A (en) * | 1954-02-04 | 1958-01-21 | Mcneilab Inc | Oxygenated indan compounds and method of making the same |
| GB1140990A (en) * | 1967-05-05 | 1969-01-22 | Warner Lambert Pharmaceutical | Novel 1,2,3,4-tetrahydro-naphthalen-2-ones and a process for the preparation thereof |
| US3547923A (en) * | 1968-03-25 | 1970-12-15 | Bristol Myers Co | Piperazyl ethyl 7h-benzocycloheptenes |
| US3644372A (en) * | 1970-01-14 | 1972-02-22 | Mcneilab Inc | 1-(4-piperidyl) indenes |
| US3850935A (en) * | 1971-10-16 | 1974-11-26 | Sumitomo Chemical Co | Process for producing piperidine derivatives by degrading quaternary piperidinium salts |
| US3974212A (en) * | 1974-05-22 | 1976-08-10 | Merck & Co., Inc. | [1-Hydroximino-2,2-disubstituted-5-indanyloxy-(or thio)]alkanoic acids |
-
1976
- 1976-02-18 US US05/659,132 patent/US4016281A/en not_active Expired - Lifetime
- 1976-02-19 SE SE7601962A patent/SE7601962L/xx unknown
- 1976-02-19 CS CS775289A patent/CS190549B2/cs unknown
- 1976-02-19 FR FR7604583A patent/FR2301253A1/fr active Granted
- 1976-02-19 CS CS761087A patent/CS190525B2/cs unknown
- 1976-02-20 HU HU76ME1952A patent/HU173756B/hu unknown
- 1976-02-20 AT AT124376A patent/AT353270B/de not_active IP Right Cessation
- 1976-02-20 IE IE340/76A patent/IE42486B1/en unknown
- 1976-02-20 DK DK72476*#A patent/DK72476A/da unknown
- 1976-02-20 DD DD191390A patent/DD124977A5/xx unknown
- 1976-02-20 LU LU74390A patent/LU74390A1/xx unknown
- 1976-02-20 GB GB686076A patent/GB1477293A/en not_active Expired
- 1976-02-20 ES ES445367A patent/ES445367A1/es not_active Expired
- 1976-02-20 NL NL7601762A patent/NL7601762A/xx not_active Application Discontinuation
- 1976-02-22 IL IL49080A patent/IL49080A/xx unknown
- 1976-02-23 CA CA246,346A patent/CA1081233A/en not_active Expired
- 1976-02-23 JP JP51020544A patent/JPS51110573A/ja active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005085228A1 (ja) * | 2004-03-05 | 2005-09-15 | Banyu Pharmaceutical Co., Ltd. | シクロアルカノピリジン誘導体 |
| JP2015528811A (ja) * | 2012-07-27 | 2015-10-01 | バイオジェン・エムエイ・インコーポレイテッドＢｉｏｇｅｎ ＭＡ Ｉｎｃ． | Ｓ１ｐ調節剤および／またはａｔｘ調節剤である化合物 |
| JP2020533328A (ja) * | 2017-09-07 | 2020-11-19 | タイワンジェ ファーマシューティカルズ カンパニー リミテッドＴａｉｗａｎｊ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏ．， Ｌｔｄ． | ベンゼン縮合複素環誘導体およびその医薬組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2301253A1 (fr) | 1976-09-17 |
| AT353270B (de) | 1979-11-12 |
| GB1477293A (en) | 1977-06-22 |
| CA1081233A (en) | 1980-07-08 |
| NL7601762A (nl) | 1976-08-24 |
| SE7601962L (sv) | 1976-08-23 |
| US4016281A (en) | 1977-04-05 |
| IL49080A (en) | 1979-09-30 |
| ATA124376A (de) | 1979-04-15 |
| DK72476A (da) | 1976-08-23 |
| IE42486B1 (en) | 1980-08-13 |
| IL49080A0 (en) | 1976-04-30 |
| IE42486L (en) | 1976-08-22 |
| CS190525B2 (en) | 1979-05-31 |
| HU173756B (hu) | 1979-08-28 |
| CS190549B2 (en) | 1979-05-31 |
| ES445367A1 (es) | 1977-10-01 |
| LU74390A1 (US08118993-20120221-C00002.png) | 1977-09-12 |
| DD124977A5 (US08118993-20120221-C00002.png) | 1977-03-23 |
| FR2301253B1 (US08118993-20120221-C00002.png) | 1979-09-21 |
